PMID- 17160088 OWN - NLM STAT- MEDLINE DCOM- 20071219 LR - 20220408 IS - 0307-0565 (Print) IS - 0307-0565 (Linking) VI - 31 IP - 7 DP - 2007 Jul TI - The SREBF-1 locus is associated with type 2 diabetes and plasma adiponectin levels in a middle-aged Austrian population. PG - 1099-103 AB - CONTEXT: The sterol regulatory element-binding protein-1c (SREBP-1c) is a transcription factor involved in the regulation of lipid and glucose metabolism and has been implicated in the pathophysiology of type 2 diabetes mellitus (T2DM). OBJECTIVE: We aimed to confirm associations of the SREBF-1 gene with T2DM in an Austrian population and to study possible associations with diabetes-related quantitative traits. DESIGN, SETTINGS AND PARTICIPANTS: We genotyped a diabetic cohort (n=446) along with a control group (n=1524) for a common C/G variation that is located in exon 18c (rs2297508) and has been associated with obesity and T2DM in French populations. MAIN OUTCOME MEASURES: Body mass index (BMI), indices of insulin sensitivity and beta-cell function, plasma adiponectin, T2DM and single-nucleotide polymorphism rs2297508. RESULTS: Genotype distributions associated with rs2297508 differed by T2DM status (P=0.0045), but not by BMI. The variant G allele was associated with a modest, but significant, increase in the prevalence of T2DM after adjustment for age, sex and BMI (G/G: odds ratios (OR) (95% confidence intervals)=1.45 (0.99-2.11) and G/C: OR=1.37 (1.04-1.81)). In a cross-sectional population of non-diabetic subjects, associations of rs2297508 genotypes with plasma adiponectin levels adjusted for age, sex and BMI (P=0.0017) were observed in that the risk G/G genotype displayed the lowest adiponectin levels. CONCLUSIONS: We observed associations of rs2297508 with T2DM prevalence and plasma adiponectin. SREBP-1c has been implicated in the regulation of adiponectin gene expression. Our results therefore raise the possibility that sequence variations at the SREBF-1 gene locus might contribute to T2DM risk, at least in part, by altering circulating adiponectin levels. FAU - Felder, T K AU - Felder TK AD - Department of Laboratory Medicine, Paracelsus Private Medical University, Salzburg, Austria. FAU - Oberkofler, H AU - Oberkofler H FAU - Weitgasser, R AU - Weitgasser R FAU - Mackevics, V AU - Mackevics V FAU - Krempler, F AU - Krempler F FAU - Paulweber, B AU - Paulweber B FAU - Patsch, W AU - Patsch W LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20061212 PL - England TA - Int J Obes (Lond) JT - International journal of obesity (2005) JID - 101256108 RN - 0 (Adiponectin) RN - 0 (SREBF1 protein, human) RN - 0 (Sterol Regulatory Element Binding Protein 1) SB - IM MH - Adiponectin/*blood MH - Aged MH - Austria/epidemiology MH - Body Mass Index MH - Case-Control Studies MH - Diabetes Mellitus, Type 2/*epidemiology/*genetics/metabolism MH - Female MH - Genetic Predisposition to Disease/epidemiology MH - Genetic Variation MH - Genotype MH - Humans MH - Insulin Resistance MH - Male MH - Middle Aged MH - *Polymorphism, Single Nucleotide MH - Prevalence MH - Risk Factors MH - Sterol Regulatory Element Binding Protein 1/*genetics/metabolism EDAT- 2006/12/13 09:00 MHDA- 2007/12/20 09:00 CRDT- 2006/12/13 09:00 PHST- 2006/12/13 09:00 [pubmed] PHST- 2007/12/20 09:00 [medline] PHST- 2006/12/13 09:00 [entrez] AID - 0803505 [pii] AID - 10.1038/sj.ijo.0803505 [doi] PST - ppublish SO - Int J Obes (Lond). 2007 Jul;31(7):1099-103. doi: 10.1038/sj.ijo.0803505. Epub 2006 Dec 12.